Class IITerminatedD-0533-2021
Drug recall · June 2, 2021
TOBREX 0.3% 3.5GM OPTH recall
Why: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TOBREX 0.3% 3.5GM OPTH; NDC/UPC 65064435; RX; OINTMENT
- Lots / codes
20B14E
- Quantity
- 28 tubes
- Company
- Cardinal Health Inc., Dublin, OH
- Distribution
- FL, GA, SC
- Initiated
- March 15, 2021 · Voluntary: Firm initiated
- Classified
- May 24, 2021
- Reported
- June 2, 2021
- Ended
- June 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedJun 2, 2021THERAPEUTIC M 130Cardinal Health Inc. · D-0400-2021Class IITerminatedJun 2, 2021NIACIN 250MG 110Cardinal Health Inc. · D-0401-2021Class IITerminatedJun 2, 2021Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36Cardinal Health Inc. · D-0402-2021Class IITerminatedJun 2, 2021Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodiumCardinal Health Inc. · D-0403-2021Class IITerminatedJun 2, 2021Norvir Ritonavir Tablets 100 mg 30 TabletsCardinal Health Inc. · D-0404-2021Class IITerminatedJun 2, 2021SynthroidCardinal Health Inc. · D-0405-2021Class IITerminatedJun 2, 2021METHOCARBAMOL 500MG 500Cardinal Health Inc. · D-0406-2021Class IITerminatedJun 2, 2021FENOFIBRATE CAPSULESCardinal Health Inc. · D-0407-2021Class IITerminatedJun 2, 2021OFLOXACIN 0.3% 5ML OPTHCardinal Health Inc. · D-0408-2021Class IITerminatedJun 2, 2021LIDOCAINE HCL VISC 2% 100MLCardinal Health Inc. · D-0409-2021Class IITerminatedJun 2, 2021Atropine Sulfate Ophthalmic SolutionCardinal Health Inc. · D-0410-2021Class IITerminatedJun 2, 2021COSOPT (Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution)Cardinal Health Inc. · D-0411-2021
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tobrex
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.